Patritumab deruxtecan is under clinical development by Daiichi Sankyo and currently in Phase II for Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis). According to ...
Ascites in patients with cancer is not necessarily caused by peritoneal carcinomatosis. Further studies are needed to assess whether survival depends on ascites characteristics. Third, this study did ...
Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer TA61 27 May 2003 27 May 2003 Guidance on the use of drugs for early thrombolysis in the treatment of acute ...